by Maria Zannes | Oct 13, 2024 | Articles, News
With a San Antonio biotech firm’s test, your phlegm could help save you from cancer. As published by the San Antonio Express-News By Brandon Lingle, Staff Writer The screening method developed by bio Affinity Technologies Inc. uses Al-aided computer analysis...
by Maria Zannes | Oct 11, 2024 | Articles, News
The Alamo City company has gained new commercial access that could greatly expand its reach and its revenue. As published in the San Antonio Business Journal By W. Scott Bailey – Senior Reporter, San Antonio Business Journal BioAffinity Technologies Inc. has reached a...
by Maria Zannes | Oct 10, 2024 | Press Releases
Edwards rejoins the Company after serving as interim CFO SAN ANTONIO, TX (Oct. 10, 2024) – bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company focused on the need for noninvasive tests for the detection of early-stage cancer, today announced...
by Maria Zannes | Oct 9, 2024 | Press Releases
Noninvasive diagnostic test for lung cancer available to U.S. Veterans, other federal health services patients SAN ANTONIO, TX (Oct. 9, 2024) – bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company focused on the need for noninvasive tests for...
by Maria Zannes | Sep 18, 2024 | Press Releases
Peer-Reviewed Study: bioAffinity Technologies’ CyPath® Lung Test Shows Potential Significant Healthcare Savings by Reducing Unnecessary Follow-Up, Medical Complications and Overdiagnosis Study by BAMC’s Michael Morris, M.D., and VA’s Sheila Habib, M.D., evaluated...
